This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Glucovision (2014-06-19)

Starting date:
June 19, 2014
Posting date:
July 11, 2014
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-40377

Recalled Products

Glucovision

Reason

Out of specification result for sterility test.

Depth of distribution

1 hospital and 1 clinic in Ontario

Affected products

Glucovision

DIN, NPN, DIN-HIM
No market authorization
Dosage form

Glass Vials

Strength

37 [F-18]-Fludeoxyglucose (FDG) Phosphate/vial

Lot or serial number

140616FDG-2

Companies
Recalling Firm
Centre for Probe Development and Commercialization (CPDC)
1280 Main St. W. NRB-A316
Hamilton
L8S 4K1
Ontario
CANADA
Marketing Authorization Holder
Not Applicable

Date modified: